CODX CoDx Expected net earnings per share growth this year

Co-Diagnostics, Inc. (CODX) is actively recruiting biological experts to develop rapid PCR tests. The annual EPS trend provided by GURU.Markets demonstrates volatility, with 91.30 serving as the current metric level. Despite its status as a global benchmark for diagnostic accuracy, Co-Diagnostics, Inc. (CODX) is facing losses due to a decline in pandemic-era sales and the costs associated with launching the Co-Dx home platform.

Co-Diagnostics, Inc. (CODX): Earnings per share growth in current year from 07/04/2022 to 11/14/2026

Financial and market metric breakdowns for Co-Diagnostics Corp (CODX)

- current quotes and average value forecast:

Market Chart CoDx|CODX - Price Target Chart

- market capitalization data:

Market Capitalization Co-Diagnostics|CODX - Enterprise Value

- shareholders' equity book value data:

Accounting Value per Share Co-Diagnostics|CODX - Company Book Value|Market-to-Book Ratio codiagnostics.com|CODX - Cumulative Company Assets

- debt burden and liquidity indicators:

- net income and valuation ratios data:

CODX - Company Net Income|Net Profit Forecast Co-Diagnostics, Inc.|CODX - Price to Earnings Ratio|Projected Price to Earnings Ratio codiagnostics.com|CODX - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Co-Diagnostics Inc|CODX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Co-Diagnostics|CODX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months codiagnostics.com|CODX - Earnings growth in current year|Expected earnings per share growth for next year Co-Diagnostics, Inc.

- revenue and sales proceeds data:

CODX - Company Revenue|Company Future Sales Co-Diagnostics, Inc.|CODX - Market Cap to Revenue|Forward Price to Sales Co-Diagnostics

Fundamental valuation:CODX - Co-Diagnostics Corp

DNA sequencing automation and the implementation of bioinformatics algorithms at Co-Diagnostics, Inc. (CODX) directly impact operational efficiency. Mathematically, this is reflected in the dynamics of net income per common share. This metric measures the annual rate of change in EPS, revealing the inertia of revenue recovery. Analyzing the annual volatility of earnings per share allows for the timely detection of a shift in the financial cycle. It is critical for investors to track this trend to minimize drawdown risks.

Direct competitors